Cogstate Limited (ASX:CGS)
Australia · Delayed Price · Currency is AUD 3.090
+0.010 (0.32%)
Sep 3, 2026, 12:19 PM AEST
Cogstate Financials Overview
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 60.86 | 60.86 | 53.09 | 43.43 | 40.45 | 44.98 |
Revenue Growth | 8.56% | 14.64% | 22.25% | 7.36% | -10.07% | 37.57% |
Gross Profit Gross Profit Growth | 35.02 | 35.02 | 32.14 | 24.3 | 20.65 | 26.28 |
Operating Income Operating Income Growth | 14.37 | 14.37 | 13.11 | 6.17 | 2.29 | 10.95 |
Net Income Net Income Growth | 11.9 | 11.9 | 10.14 | 5.45 | 3.57 | 7.52 |
Earnings Per Share EPS Growth | 0.07 | 0.07 | 0.06 | 0.03 | 0.02 | 0.04 |
EPS Growth | 9.25% | 15.10% | 85.08% | 55.94% | -52.47% | 40.73% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Healthcare (Incl. Sport) Healthcare (Incl. Sport) Growth | 2.5 | 2.5 | 2.51 | 3.99 | 4.4 | 4.46 |
Clinical Trials (incl. Precision Recruitment Tool & Research) Clinical Trials (incl. Precision Recruitment Tool & Research) Growth | 58.37 | 58.37 | 50.58 | 39.44 | 36.05 | - |
Total Total Growth | 60.86 | 60.86 | 53.09 | 43.43 | 40.45 | 45.03 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 34.78 | 34.78 | 35.56 | 30.12 | 28.68 | 30.6 |
Total Debt Total Debt Growth | 0.36 | 0.36 | 0.47 | 0.67 | 0.38 | 1.41 |
Net Cash (Debt) Net Cash Growth | 34.42 | 34.42 | 35.09 | 29.45 | 28.3 | 29.19 |
Net Cash Growth | 2.34% | -1.91% | 19.16% | 4.08% | -3.04% | 33.26% |
Net Cash Per Share Net Cash Per Share Growth | 0.19 | 0.19 | 0.20 | 0.17 | 0.16 | 0.17 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 8.51 | 8.51 | 11.48 | 5.78 | 0.65 | 9.73 |
Capital Expenditures CapEx Growth | -0.51 | -0.51 | -0.3 | -0.45 | -0.13 | -0.42 |
Free Cash Flow Free Cash Flow Growth | 7.99 | 7.99 | 11.18 | 5.33 | 0.52 | 9.3 |
Free Cash Flow Growth | -4.15% | -28.49% | 109.57% | 920.38% | -94.38% | -39.93% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 57.53% | 57.53% | 60.53% | 55.96% | 51.04% | 58.43% |
Operating Margin | 23.61% | 23.61% | 24.70% | 14.21% | 5.67% | 24.34% |
Pretax Margin | 26.47% | 26.47% | 26.20% | 16.35% | 7.48% | 23.77% |
Profit Margin | 19.54% | 19.54% | 19.11% | 12.55% | 8.82% | 16.72% |
FCF Margin | 13.13% | 13.13% | 21.05% | 12.28% | 1.29% | 20.68% |
| Fiscal Year | Current | FY 2026 | FY 2025 |
|---|---|---|---|
| Period Ending | Sep '26 Sep 3, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 |
Dividend Per Share Dividend Per Share Growth | 0.042 | 0.030 | 0.010 |
Dividend Per Share Growth | 0% | 200.00% | - |
Dividend Yield | 1.38% | 1.61% | 0.90% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 3, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 31.76 | 26.97 | 19.05 | 23.42 | 53.31 | 24.22 |
Forward PE | 24.51 | 23.33 | 21.00 | 30.85 | 33.07 | 20.83 |
P/FCF Ratio | 45.30 | 40.14 | 17.29 | 23.93 | 363.85 | 19.58 |
PS Ratio | 5.95 | 5.27 | 3.64 | 2.94 | 4.70 | 4.05 |